The EMT process represents the critical event in the transition from early stage to invasive carcinoma [11, 57], and E-cadherin downregulation is well associated with poor prognosis, lower survival, and higher rates of metastasis in OSCC patients [58–61]. The gene discussed is CDH1; the disease is invasive carcinoma.